- Published on 25 February 2016
Technavio recently published a report on the global cochlear implant (CI) market that analyzes the key trends expected to impact this market for the period 2016-2020, reports Business wire.
Technavio is an international technology research and advisory company publishing market research on a variety of topics. In its recent report, it found that the global CI market is likely to exceed USD 2 billion by the year 2020, growing at a compound annual growth rate (CAGR) of more than 14%.
The factors the report points to for this healthy projection include an aging population and increasing prevalence of acquired hearing loss. It also reports that technological innovations in cochlear implants are expected to boost market growth over this period.
“Favorable government initiatives and reimbursement policies in emerging countries will encourage global vendors to focus on these countries. Despite the economic slowdown in the past and the limited healthcare expenditure in most countries, the global cochlear implants market has displayed good growth in the last few years,” explains Barath Palada, a lead analyst at Technavio for orthopedics and general medical devices.
Currently, more than 45,000 CIs are sold worldwide each year. Cochlear Ltd. and MED-EL dominated the market in 2015 with a 70% market share. The three main trends explained in the report are innovation with next-generation sound processors becoming available, high growth potential in emerging markets such as China, and the introduction of rechargeable CI devices.
Source: Business Wire
£ performance €
British and Irish hearing device producers have confirmed a continuing brightening of the economic picture for Q3, 2020, as the market recovers from the ravages of spring lockdowns.
New research using improved microscopy techniques suggests that age-related hearing loss is primarily caused by damage to inner ear sensory cells, pointing to regeneration of hair cells as a potential solvent future therapy.
Does COVID-19 cause hearing loss? The UK's Manchester Biomedical Centre has won funding to help answer this hotspot question by carrying out a comprehensive clinical and diagnostic research study on post-hospitalised COVID-19 patients.
The world's first two robotics-assisted cochlear implant (CI) insertions have been achieved by US firm iotaMotion through its iotaSOFT system, an investigational surgical tool currently in clinical evaluation.
Over the months since coronavirus restrictions were first introduced, the flow of investigation into hearing has been obstructed and, to some extent, rerouted. Though manufacturers' installations have been hard hit, perhaps the worst hit research centres have been universities.
Jabra, the headset engineering brand of GN Group, has launched a new Elite 85t earbud set, plus an update for its Elite 75t series; an Active Noise Cancellation (ANC) chip is built into both ranges.[ ... ]
Hot on the heels of the recent launch of its Livio Edge AI hearing aid, the US manufacturer Starkey has now expanded its features to include a "first-of-its-kind" speech enhancement feature, and technology to help wearers find their smartphones.[ ... ]
The success of Sonova's Phonak Marvel hearing aids needed a guarantee of an afterlife to keep the story going: Audéo Paradise is how the core prayers of the Switzerland-based group's consumers have been answered.[ ... ]